Department of Ophthalmology, Cantonal Hospital Aarau, 5000, Aarau, Switzerland.
Department of Clinical Neuroscience, Section of Ophthalmology and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3413-3419. doi: 10.1007/s00417-021-05222-z. Epub 2021 Jun 7.
Diagnosis of orbital compartment syndrome is mainly based on clinical findings, such as intraocular pressure and proptosis, which try to estimate the orbital compartment pressure. However, the reliability of these surrogates is unclear. Current techniques for the direct measurement of orbital compartment pressure are widely experimental and impractical in the clinical setting. Our aim was to explore the feasibility of minimally invasive needle manometry for direct measurement of orbital compartment pressure under reproducible conditions in an in vivo model of orbital congestion. We further sought to evaluate intraocular pressure and proptosis as indicators for elevated orbital compartment pressure.
A total of 7 ml of mepivacaine 2% solution was injected into the orbital compartment in 20 patients undergoing cataract surgery under local anesthesia. A commercially available single-use manometer device was inserted between the syringe and the injection needle to measure the orbital compartment pressure for each milliliter of intraorbital volume increment. Additionally, intraocular pressure (subgroup A; n = 10) or axial globe position (subgroup B; n = 10) were measured.
Needle manometry allowed for rapid and continuous measurement of orbital compartment pressure. Overall mean orbital compartment pressure increased from 2.5 mmHg pre- to 12.8 mmHg post-interventionally. Both, intraocular pressure (Spearman's correlation coefficient rs = 0.637, p < 0.0001) and proptosis (rs = 0.675, p < 0.0001) correlated strongly with the orbital compartment pressure.
Needle manometry appears to be a feasible minimally invasive instrument to directly measure orbital compartment pressure, showing promises for a more routine application in managing orbital compartment syndrome. The results further suggest that both elevated intraocular pressure and proptosis are valuable indicators for orbital compartment syndrome.
眼眶间隔综合征的诊断主要基于临床发现,如眼压和眼球突出,这些发现试图估计眼眶间隔压力。然而,这些替代物的可靠性尚不清楚。目前用于直接测量眼眶间隔压力的技术在临床环境中广泛是实验性的和不切实际的。我们的目的是探索在眼眶充血的体内模型中,在可重复的条件下,使用微创针压计直接测量眼眶间隔压力的可行性。我们还试图评估眼压和眼球突出作为眼眶间隔压力升高的指标。
在局部麻醉下接受白内障手术的 20 名患者中,将 2%的甲哌卡因 7 毫升注入眼眶间隔。在注射器和注射针之间插入一种市售的一次性使用压力计装置,以测量每毫升眼眶容积增量的眼眶间隔压力。此外,还测量了眼压(亚组 A;n = 10)或轴向眼球位置(亚组 B;n = 10)。
针压计允许快速连续测量眼眶间隔压力。总体平均眼眶间隔压力从介入前的 2.5mmHg 增加到 12.8mmHg。眼压(Spearman 相关系数 rs = 0.637,p < 0.0001)和眼球突出(rs = 0.675,p < 0.0001)均与眼眶间隔压力密切相关。
针压计似乎是一种可行的微创仪器,可以直接测量眼眶间隔压力,为管理眼眶间隔综合征提供了更常规的应用前景。结果还表明,眼压升高和眼球突出都是眼眶间隔综合征的有价值指标。